Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| National Vision Holdings, Inc.EYE · Entity 1716 | Director · Executive Chairman | March 06, 2026 | March 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
National Vision Holdings, Inc.
Report date March 06, 2026 · Filed March 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 694,880 |
Ending reported balance
After 2026-03-06 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-03-06 · Exercise / conversion · Acquired 54,824 · Balance 726,900 F1: Each restricted stock unit converts into common stock on a one-for-one basis. Row 2 · 2026-03-06 · Tax withholding · Disposed 24,419 · Balance 702,481 F2: Reflects payment of tax liability by withholding securities incident to vesting of restricted stock units. Row 3 · 2026-03-06 · Sale · Disposed 7,601 · Balance 694,880 F3: This sale was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 4, 2025. F4: Price represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $29.50 to $29.71. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. |
| Common StockSEC Table I · non-derivative | IndirectHeld by Trust | 359,359 |
Reported balance
After 2026-03-06 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2026-03-06 · Sale · Disposed 4,071 · Balance 359,359 F3: This sale was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 4, 2025. F5: Price represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $29.50 to $29.70. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 137,971 |
Reported balance
After 2026-03-06 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-06 · Exercise / conversion · Disposed 54,824 · Balance 137,971 F1: Each restricted stock unit converts into common stock on a one-for-one basis. F6: On March 7, 2025, the reporting person was granted 164,474 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 209,656 |
Reported balance
After 2026-03-06 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-06 · Grant · Acquired 71,685 · Balance 209,656 F1: Each restricted stock unit converts into common stock on a one-for-one basis. F7: One-third of these restricted stock units will vest on each anniversary of the grant date, March 6, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit converts into common stock on a one-for-one basis.
F2: Reflects payment of tax liability by withholding securities incident to vesting of restricted stock units.
F3: This sale was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 4, 2025.
F4: Price represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $29.50 to $29.71. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
F5: Price represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $29.50 to $29.70. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
F6: On March 7, 2025, the reporting person was granted 164,474 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.
F7: One-third of these restricted stock units will vest on each anniversary of the grant date, March 6, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2019 Filed Apr 5, 2019 16:34 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 30,000 | $30.14 | $904,260.00 |
DisclosureSEC source: 0001181253-19-000012 · wf-form4_155449643812038.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,037 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018, as amended on November 28, 2018. The plan provides for monthly sales through June 5, 2019. F2 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $29.96 to $30.76. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:36 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 5,000 | $31.70 | $158,480.00 |
DisclosureSEC source: 0001181253-19-000010 · wf-form4_155208100478173.xml · nonDerivative · entry 3 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trust Disclosed balance after: 188,430 F4 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the Trust on November 30, 2018. The plan provides for monthly sales through June 5, 2019. F5 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $31.43 to $32.207. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:36 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 1,399 | $32.01 | $44,777.79 |
DisclosureSEC source: 0001181253-19-000010 · wf-form4_155208100478173.xml · nonDerivative · entry 2 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,037 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018, as amended on November 28, 2018. The plan provides for monthly sales through June 5, 2019. F3 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $31.88 to $32.207. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:36 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 28,601 | $31.24 | $893,352.24 |
DisclosureSEC source: 0001181253-19-000010 · wf-form4_155208100478173.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,436 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018, as amended on November 28, 2018. The plan provides for monthly sales through June 5, 2019. F2 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $30.83 to $31.825. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:32 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | GrantStock Option (Right to Buy) · Derivative | 79,114 | $35.19 Strike: $35.19 | $2,784,021.66 |
DisclosureSEC source: 0001181253-19-000008 · wf-form4_155182154571643.xml · derivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,114 Underlying: Common Stock · 79,114 shares Expires 2029-03-01 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 1, 2020. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 16:27 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 5,000 | $31.78 | $158,900.00 |
DisclosureSEC source: 0001181253-19-000006 · wf-form4_154966123543628.xml · nonDerivative · entry 3 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trust Disclosed balance after: 193,430 F4 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the Trust on November 30, 2018. The plan provides for monthly sales through June 5, 2019. F5 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $31.49 to $32.385. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 16:27 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 1,879 | $32.37 | $60,828.87 |
DisclosureSEC source: 0001181253-19-000006 · wf-form4_154966123543628.xml · nonDerivative · entry 2 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,037 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018, as amended on November 28, 2018. The plan provides for monthly sales through June 5, 2019. F3 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $32.242 to $32.385. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 16:27 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 28,121 | $31.57 | $887,751.85 |
DisclosureSEC source: 0001181253-19-000006 · wf-form4_154966123543628.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,916 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018, as amended on November 28, 2018. The plan provides for monthly sales through June 5, 2019. F2 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $31.32 to $32.05. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 16:33 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 5,000 | $30.00 | $150,000.00 |
DisclosureSEC source: 0001181253-19-000004 · wf-form4_154758797094395.xml · nonDerivative · entry 2 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Trust Disclosed balance after: 198,430 F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the Trust on November 30, 2018. The plan provides for monthly sales through June 5, 2019. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 16:33 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 20,000 | $30.00 | $600,000.00 |
DisclosureSEC source: 0001181253-19-000004 · wf-form4_154758797094395.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,037 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018, as amended on November 28, 2018. The plan provides for monthly sales through June 5, 2019. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 16:33 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 10,000 | $27.79 | $277,940.00 |
DisclosureSEC source: 0001181253-19-000002 · wf-form4_154663758883610.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,037 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018. F2 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $27.45 to $28.10. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 16:11 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 400 | $36.04 | $14,415.20 |
DisclosureSEC source: 0001181253-18-000020 · wf-form4_154421707419857.xml · nonDerivative · entry 2 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,037 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018. F3 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $35.93 to $36.10. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 16:11 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 9,600 | $35.24 | $338,342.40 |
DisclosureSEC source: 0001181253-18-000020 · wf-form4_154421707419857.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,437 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018. F2 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $34.86 to $35.83. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 16:12 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | GrantStock Option (Right to Buy) · Derivative | 205,974 | $4.27 Strike: $4.27 | $879,508.98 |
DisclosureSEC source: 0001181253-18-000018 · wf-form4_154283471161535.xml · derivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816,266 Underlying: Common Stock · 205,974 shares Expires 2024-03-13 F1 · shares: On March 13, 2014, the reporting person was granted stock options, subject to time-based and performance-based vesting. On November 1, 2018, a liquidity event with respect to such performance-based stock options occurred as a result of sales by the Issuer's sponsor stockholders and 205,974 stock options which had previously not been reported were deemed earned. F2 · derivative.exercise_date: Of the 816,266 stock options reported herein, 694,209 are vested and the remaining 122,059 time-based stock options will vest on March 13, 2019. An additional 343,289 stock options which remain subject to liquidity-event performance-based vesting conditions are not included in the table above. Read SEC document |
| November 07, 2018 Filed Nov 8, 2018 16:23 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 10,000 | $44.21 | $442,070.00 |
DisclosureSEC source: 0001181253-18-000016 · wf-form4_154171221564095.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 543,037 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018. F2 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $43.70 to $44.59. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 03, 2018 Filed Oct 5, 2018 17:09 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 10,000 | $43.76 | $437,600.00 |
DisclosureSEC source: 0001181253-18-000014 · wf-form4_153877168244066.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 553,037 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018. F2 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $43.19 to $43.98. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 05, 2018 Filed Sep 6, 2018 16:12 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 10,000 | $44.43 | $444,300.00 |
DisclosureSEC source: 0001181253-18-000012 · wf-form4_153626472918942.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 563,037 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018. F2 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $44.285 to $44.708. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 16:11 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | GiftCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181253-18-000010 · wf-form4_153488225072652.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,037 Read SEC document |
| August 02, 2018 Filed Aug 2, 2018 16:29 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | GrantStock Option (Right to Buy) · Derivative | 45,772 | $4.27 Strike: $4.27 | $195,446.44 |
DisclosureSEC source: 0001181253-18-000007 · wf-form4_153324176089237.xml · derivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610,292 Underlying: Common Stock · 45,772 shares Expires 2024-03-13 F1 · shares: On March 13, 2014, the reporting person was granted stock options, subject to time-based and performance-based vesting. On August 2, 2018, a liquidity event with respect to such performance-based stock options occurred as a result of sales by the Issuer's sponsor stockholders and 45,772 stock options which had previously not been reported were deemed earned. F2 · derivative.exercise_date: Of the 610,292 stock options reported herein, 488,235 are vested and the remaining 122,059 time-based stock options will vest on March 13, 2019. An additional 549,263 stock options which remain subject to liquidity-event performance-based vesting conditions are not included in the table above. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 16:32 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 10,000 | $40.55 | $405,530.00 |
DisclosureSEC source: 0001181253-18-000008 · wf-form4_153332833296258.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,037 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018. F2 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $40.26 to $40.84. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 16:17 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | GrantStock Option (Right to Buy) · Derivative | 320,403 | $4.27 Strike: $4.27 | $1,368,120.81 |
DisclosureSEC source: 0001181253-18-000004 · wf-form4_153315465350092.xml · derivative · entry 3 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,520 Underlying: Common Stock · 320,403 shares Expires 2024-03-13 F2 · shares: On March 13, 2014, the reporting person was granted stock options, subject to time-based and performance-based vesting. On July 30, 2018, a liquidity event with respect to such performance-based stock options occurred as a result of sales by the Issuer's sponsor stockholders and 320,403 stock options which had previously not been reported were deemed earned. F3 · derivative.exercise_date: Of the 564,520 stock options reported herein, 442,463 are vested and the remaining 122,059 time-based stock options will vest on March 13, 2019. An additional 595,035 stock options which remain subject to liquidity-event performance-based vesting conditions are not included in the table above. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 16:17 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 150,000 | $38.26 | $5,738,910.00 |
DisclosureSEC source: 0001181253-18-000004 · wf-form4_153315465350092.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,037 F1 · price: This amount represents the secondary public offering price per share of common stock of National Vision Holdings, Inc. of $39.75, less the underwriting discount of $1.4906 per share. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 16:41 UTC | National Vision Holdings, Inc. EYE · Entity 1716 | SaleCommon Stock | 10,000 | $38.05 | $380,500.00 |
DisclosureSEC source: 0001181253-18-000002 · wf-form4_153090968423601.xml · nonDerivative · entry 1 FAHS L READE · CIK 0001181253 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763,037 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on May 29, 2018. The plan provides for monthly sales through June 5, 2019. F2 · price: Price represents the weighted average sales price. The shares were sold pursuant to a single order in multiple transactions as prices ranging from $37.71 to $38.69. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.